These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25995219)

  • 1. New blood: Creative funding of disease-specific research.
    Seaman WE; Locksley RM; Welsh MJ
    Sci Transl Med; 2015 May; 7(288):288ed5. PubMed ID: 25995219
    [No Abstract]   [Full Text] [Related]  

  • 2. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can emerging drug classes improve R&D productivity?
    Meier C; Cairns-Smith S; Schulze U
    Drug Discov Today; 2013 Jul; 18(13-14):607-9. PubMed ID: 23702084
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to differentiate between uncontrolled and severe asthma].
    Barzok M
    MMW Fortschr Med; 2016 May; 158(10):73-4. PubMed ID: 27221441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Asthma guideline for family practice].
    Schumacher B
    MMW Fortschr Med; 2016 Apr; 158(8):30. PubMed ID: 27116146
    [No Abstract]   [Full Text] [Related]  

  • 6. APS comments on the 21st century bioeconomy.
    Physiologist; 2012 Feb; 55(1):23-5. PubMed ID: 22439365
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategic R&D transactions in personalized drug development.
    Makino T; Lim Y; Kodama K
    Drug Discov Today; 2018 Jul; 23(7):1334-1339. PubMed ID: 29574213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 9. Fostering innovation and discovery in biomedical research.
    Cech TR
    JAMA; 2005 Sep; 294(11):1390-3. PubMed ID: 16174699
    [No Abstract]   [Full Text] [Related]  

  • 10. Safeguarding innovation through an economic downturn.
    Barker R
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):347-9. PubMed ID: 20715908
    [No Abstract]   [Full Text] [Related]  

  • 11. U-BIOPRED: evaluation of the value of a public-private partnership to industry.
    Riley JH; Erpenbeck VJ; Matthews JG; Holweg CTJ; Compton C; Seibold W; Higenbottam T; Wagers S; Rowe A; Myles D;
    Drug Discov Today; 2018 Sep; 23(9):1622-1634. PubMed ID: 29936248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A guide for success as a clinical investigator.
    Provenzale D
    Gastroenterology; 2012 Mar; 142(3):418-21. PubMed ID: 22266151
    [No Abstract]   [Full Text] [Related]  

  • 13. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Professional medical associations and the opportunity to promote breakthrough biomedical innovation.
    Xu S; Xu RS; Breslin J; Raff AB; Garibyan L; Sunshine JC; Ju WD
    Drug Discov Today; 2018 Aug; 23(8):1453-1456. PubMed ID: 29391260
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness of asthma management strategies.
    Thomas M; Haughney J; Price D
    Pharmacoeconomics; 2002; 20(11):789. PubMed ID: 12201798
    [No Abstract]   [Full Text] [Related]  

  • 16. Pressure point. When coughing up is essential.
    Cooper C
    Health Serv J; 2000 Nov; 110(5733):suppl 1. PubMed ID: 11138527
    [No Abstract]   [Full Text] [Related]  

  • 17. Asthma medication.
    Rogol PR
    Conn Med; 2008 Aug; 72(7):441. PubMed ID: 18763675
    [No Abstract]   [Full Text] [Related]  

  • 18. Precompetitive consortia in biomedicine--how are we doing?
    Mittleman B; Neil G; Cutcher-Gershenfeld J
    Nat Biotechnol; 2013 Nov; 31(11):979-85. PubMed ID: 24213770
    [No Abstract]   [Full Text] [Related]  

  • 19. The economics of resistant pathogens and antibiotic innovation.
    McKellar MR; Chernew ME; Fendrick AM
    Am J Manag Care; 2014 Mar; 20(3):193-7. PubMed ID: 24884749
    [No Abstract]   [Full Text] [Related]  

  • 20. NIH innovation letter.
    Ness RB
    Ann Epidemiol; 2006 May; 16(5):411-2. PubMed ID: 16647632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.